Rollins, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Rollins, Inc.
ROL · a US exchange · USD · Market cap $18.5B · 22,000 employees
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services and protection to residential and commercial customers in the United States and internationally.
Not yet scoredPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price37.97 USD at the 19 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 19 Nov 2026
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 3.38)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $23.40 to $33.36, base estimate $29.01 (screen dated 2026-11-19).
- Trend Markup
- Insiders insiders bought, latest filing 2026-10-29
- Positioning political selling, disclosed 2026-10-07
- Options put/call open interest 3.38, read 2026-11-19
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Rollins, Inc. holds its Markup at $37.97. The statistical read favours the buyers, held for 40 days.
| Phase | Markup |
| Quantitative state | The statistical read favours the buyers, held for 40 days |
| Price at the screen | $37.97 |
| Valuation | 35.25 trailing · 31.20 forward price to earnings |
| Values screen | Not scored · score 85.1 |
| Beta | 0.72 |
Five Screens: ROL's Results
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 33.05% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 9.63% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadThe Read, in Plain English
Rollins, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Rollins, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 33%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 19 Nov 2026: it trades above our $29.01 fair value estimate, moderate competitive moat, 6.20% revenue growth.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 30.9% above the base estimate.
Third-party analyst targets: 17 covering, consensus Buy. The average target sits −3% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere our models see it going: fair-value estimate $29.01, with a range of $23.40 to $33.36, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 31.2xexpensive even after accounting for its growth |
| Trailing P/E | 35.2xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.09 |
| EPS, forward | 1.23 |
| Revenue growth | +6.2%slow but positive growth |
| Profit margin | 13.2%thin but positive margins |
| Return on equity | 36.0%an exceptional return on shareholder capital |
| FCF yield | 3.00% |
| Dividend yield | 2.12% |
| Debt to equity | 0.81moderate, manageable leverage |
| Current ratio | 0.62below 1: short-term bills exceed liquid assets |
| Beta | 0.72steadier than the market |
| Short interest, float | 0.09% |
| 52-week range | 29.29 - 66.14 |
| Moat | MODERATE |
| Market cap | $18.5B |
| Employees | 22,000 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 11.7% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.3% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 6.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 13%. The street (16 analysts) rates it buy, with a mean price target of $64. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Rollins to Present at Upcoming Investor Conferences Yahoo Finance · 8d ago
- Citi’s Marc Van’t Sant Upgraded Rollins (ROL). Here’s the Problem Bulls Say Can Be Fixed Yahoo Finance · 9d ago
- Bonds Are Paying 5% Again, and the Repricing Has Reached Every Corner of the Market Yahoo Finance · 10d ago
- Does Earnings Miss Change The Bull Case For Rollins (ROL)? Yahoo Finance · 10d ago
- Buy, Sell, or Hold? Monday’s Top Upgrades and Downgrades: Advanced Micro Devices, Airbnb, DraftKings, L3 Harris Technologies, Molson-Coors, Nvidia, Take-Two Interactive, Uber Technologies, and More Yahoo Finance · 11d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-29 | R. Randall Rollins Voting Trust U/A Dated August 25, 1994 | 10% | P - Purchase | 1,444,402 | $49,956,665 |
| 2026-10-29 | Lor Inc | 10% | P - Purchase | 1,444,402 | $49,956,665 |
| 2026-04-30 | WILSON JOHN F | Officer and Director | 4,795 | · | |
| 2026-04-29 | GAHLHOFF JERRY JR | Chief Executive Officer | 3,629 | · | |
| 2026-04-28 | GUNNING PATRICK J. | Director | 2,692 | · | |
| 2026-04-28 | CARSON DONALD P | Director | 2,692 | · | |
| 2026-04-28 | ROLLINS PAMELA R | Director | 2,692 | · | |
| 2026-04-28 | ROLLINS TIMOTHY CURTIS | Director | 2,692 | · | |
| 2026-04-28 | MORRISON GREGORY B. | Director | 2,692 | · | |
| 2026-04-28 | HARDIN PAUL RUSSELL | Director | 2,692 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| 2026-10-15 | David Taylor | Republican | buy | 1K–15K |
| 2026-10-15 | David Taylor | Republican | buy | 1K–15K |
| 2026-10-15 | David Taylor | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $52.88 | -9.7% | $0.18 | $907 | -9.3% |
| 2 months | $54.05 | -11.6% | $0.18 | $887 | -11.3% |
| 3 months | $55.40 | -13.8% | $0.18 | $866 | -13.4% |
| 6 months | $59.11 | -19.2% | $0.37 | $814 | -18.6% |
| 1 year | $56.17 | -15.0% | $0.71 | $863 | -13.7% |
| 2 years | $45.64 | +4.7% | $1.36 | $1,076 | +7.6% |
| 3 years | $39.24 | +21.7% | $1.94 | $1,267 | +26.7% |
| 5 years | $31.23 | +53.0% | $2.89 | $1,622 | +62.2% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ROL does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.